These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 3890933

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Isolation and washing of human platelets with nitric oxide.
    Radomski MW, Palmer RM, Read NG, Moncada S.
    Thromb Res; 1988 May 15; 50(4):537-46. PubMed ID: 2842884
    [Abstract] [Full Text] [Related]

  • 3. Prostacyclin prolongs viability of washed human platelets.
    Blackwell GJ, Radomski M, Vargas JR, Moncada S.
    Biochim Biophys Acta; 1982 Sep 17; 718(1):60-5. PubMed ID: 6291622
    [Abstract] [Full Text] [Related]

  • 4. Biological actions of prostacyclin and its pharmacological use in platelet studies.
    Moncada S, Whittle BJ.
    Adv Exp Med Biol; 1985 Sep 17; 192():337-58. PubMed ID: 3010671
    [No Abstract] [Full Text] [Related]

  • 5. Use of prostacyclin to inhibit activation of platelets during preparation of platelet concentrates.
    Menitove JE, Frenzke M, Aster RH.
    Transfusion; 1984 Sep 17; 24(6):528-31. PubMed ID: 6390814
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A combined method for the preparation of washed human platelets using prostacyclin and gel filtration.
    Yamamoto K, Hirai A, Tamura Y, Yoshida S.
    Thromb Res; 1988 Jun 01; 50(5):733-8. PubMed ID: 3046041
    [No Abstract] [Full Text] [Related]

  • 8. Stabilization of standard platelet concentrates and minimization of the platelet storage lesion by a prostacyclin analogue.
    Elias M, Heethuis A, Weggemans M, Bom V, Blom N, McShine RL, Halie MR, Smit Sibinga CT.
    Ann Hematol; 1992 Jun 01; 64(6):292-8. PubMed ID: 1379080
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. An improved method for washing of human platelets with prostacyclin.
    Radomski M, Moncada S.
    Thromb Res; 1983 May 15; 30(4):383-9. PubMed ID: 6351341
    [No Abstract] [Full Text] [Related]

  • 12. Preservation of platelet function in cryopreserved platelet concentrates with prostacyclin.
    Johnson EJ, Mackie IJ, Machin SJ, Brozović B.
    Clin Lab Haematol; 1984 May 15; 6(2):141-4. PubMed ID: 6207975
    [Abstract] [Full Text] [Related]

  • 13. Influence on platelet activity and red cell fluidity of epoprostenol and two stable prostacyclin analogues in vitro.
    Maurin N.
    Arzneimittelforschung; 1986 Aug 15; 36(8):1180-3. PubMed ID: 3096342
    [Abstract] [Full Text] [Related]

  • 14. The aggregation of isolated human platelets in the presence of lipoproteins and prostacyclin.
    Hassall DG, Owen JS, Bruckdorfer KR.
    Biochem J; 1983 Oct 15; 216(1):43-9. PubMed ID: 6360159
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Decreased platelet sensitivity to prostacyclin (epoprostenol) during hemodialysis.
    Kristensen SD, Knudsen F, Nielsen AH, Ring T.
    Clin Nephrol; 1984 Apr 15; 21(4):230-4. PubMed ID: 6375926
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.